DK1091740T3 - Halvfaste vandige præparater til oral applikation af toltrazuril-sulfon - Google Patents

Halvfaste vandige præparater til oral applikation af toltrazuril-sulfon

Info

Publication number
DK1091740T3
DK1091740T3 DK99926343T DK99926343T DK1091740T3 DK 1091740 T3 DK1091740 T3 DK 1091740T3 DK 99926343 T DK99926343 T DK 99926343T DK 99926343 T DK99926343 T DK 99926343T DK 1091740 T3 DK1091740 T3 DK 1091740T3
Authority
DK
Denmark
Prior art keywords
semi
oral application
aqueous preparations
solid aqueous
toltrazuril sulfone
Prior art date
Application number
DK99926343T
Other languages
English (en)
Inventor
Matthias Kuhn
Bettina Rohde
Helmut Schnabel
Hans-Christian Mundt
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK1091740T3 publication Critical patent/DK1091740T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK99926343T 1998-06-02 1999-05-20 Halvfaste vandige præparater til oral applikation af toltrazuril-sulfon DK1091740T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19824483A DE19824483A1 (de) 1998-06-02 1998-06-02 Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
PCT/EP1999/003462 WO1999062519A1 (de) 1998-06-02 1999-05-20 Halbfeste wässrige zubereitungen für orale applikation von toltrazuril-sulfon

Publications (1)

Publication Number Publication Date
DK1091740T3 true DK1091740T3 (da) 2005-01-24

Family

ID=7869584

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99926343T DK1091740T3 (da) 1998-06-02 1999-05-20 Halvfaste vandige præparater til oral applikation af toltrazuril-sulfon

Country Status (18)

Country Link
US (1) US6436935B1 (da)
EP (1) EP1091740B1 (da)
JP (1) JP4958336B2 (da)
KR (1) KR100717832B1 (da)
CN (1) CN1137687C (da)
AT (1) ATE279926T1 (da)
AU (1) AU756372B2 (da)
BR (1) BR9910936B1 (da)
CA (1) CA2333680C (da)
DE (2) DE19824483A1 (da)
DK (1) DK1091740T3 (da)
ES (1) ES2232143T3 (da)
HK (1) HK1038702B (da)
HU (1) HU228500B1 (da)
NZ (1) NZ508513A (da)
PL (1) PL193534B1 (da)
PT (1) PT1091740E (da)
WO (1) WO1999062519A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
DE10040174A1 (de) 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10040110A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
SI22751A (sl) * 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP3578182A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulations containing triazinones and iron with a low amount of free iron ions
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718799A1 (de) * 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
DE3300793A1 (de) * 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
US4755386A (en) * 1986-01-22 1988-07-05 Schering Corporation Buccal formulation
DE19519821A1 (de) * 1995-05-31 1996-12-05 Bayer Ag Mittel gegen parasitäre Protozoen
DE19603984A1 (de) * 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
WO1998043644A1 (en) * 1997-03-31 1998-10-08 David Granstrom Formulations and methods to treat and prevent equine protozoal myeloencephalitis

Also Published As

Publication number Publication date
HUP0102007A2 (hu) 2001-11-28
KR100717832B1 (ko) 2007-05-11
AU756372B2 (en) 2003-01-09
KR20010043453A (ko) 2001-05-25
PL344329A1 (en) 2001-10-22
CA2333680C (en) 2009-05-19
US6436935B1 (en) 2002-08-20
HU228500B1 (en) 2013-03-28
JP4958336B2 (ja) 2012-06-20
BR9910936B1 (pt) 2010-11-16
PT1091740E (pt) 2004-12-31
EP1091740A1 (de) 2001-04-18
PL193534B1 (pl) 2007-02-28
HK1038702A1 (en) 2002-03-28
WO1999062519A1 (de) 1999-12-09
NZ508513A (en) 2002-09-27
HUP0102007A3 (en) 2003-10-28
CN1304310A (zh) 2001-07-18
CA2333680A1 (en) 1999-12-09
ES2232143T3 (es) 2005-05-16
EP1091740B1 (de) 2004-10-20
CN1137687C (zh) 2004-02-11
JP2002516862A (ja) 2002-06-11
DE19824483A1 (de) 1999-12-09
AU4364299A (en) 1999-12-20
ATE279926T1 (de) 2004-11-15
BR9910936A (pt) 2001-03-06
HK1038702B (zh) 2004-12-10
DE59910906D1 (de) 2004-11-25

Similar Documents

Publication Publication Date Title
JPH1072351A5 (da)
CY1109567T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δροσπιρενονη
ATE190834T1 (de) Orale zusammensetzung gegen zahnbelag
FR2807322B1 (fr) Composition, notamment cosmetique, comprenant de l'acide ascorbique en association avec un derive d'acide ascorbique
TR199700803T1 (xx) Trombin-inhibit�rleri olarak yeni dipeptidik amidinler.
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
HK1039893A1 (zh) 5-氨基-γ-酮戊酸的纖乳狀液
ATE279926T1 (de) Halbfeste wässrige zubereitungen für orale applikation von toltrazuril-sulfon
DK1149910T3 (da) Farmaceutisk præparat til behandling af papillomavirustumorer og -infektion
CA2172603A1 (en) Solid Substances Comprising Valproic Acid and Sodium Valproate
DE59708723D1 (de) Oral applizierbare granulate von hexahydropyrazinderivaten
BR0011864A (pt) Formulações farmacêuticas
RU2002113885A (ru) Мазь ибупрофена, приготовленная на полиэтиленоксидной основе, обладающая противовоспалительным действием
RU95110962A (ru) Мазь для лечения гнойно-воспалительных процессов
DE69806923D1 (de) Molluskizide
RU97114385A (ru) Гиполипидемическое и гепатопротекторное средство
CA2276719A1 (en) Anilide derivatives and antiarrhythmic agents containing the same
RU97112735A (ru) Зубной эликсир
ATE275577T1 (de) Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung
RU97107192A (ru) Фармацевтическая композиция
RU97107713A (ru) Мазь бутадиона, приготовленная на геле полиэтиленоксида-1500, обладающая противовоспалительным действием
RU2001117147A (ru) Ранозаживляющее средство - "мазь тиотриазолина"
RU96115480A (ru) Лекарственное средство, обладающее холелитолитическим действием
RU98119825A (ru) Клеевая композиция
RU98102892A (ru) Состав основы для лекарственных пленок